CLCS

Cell Source (QB) Stock Price

1.15
0.00 (0.0%)
1.15
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Cell Source Inc (QB) CLCS OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.15 16:28:29
Close Price Low Price High Price Open Price Previous Close
1.15 1.14 1.15 1.14 1.15
Bid Price Ask Price Spread News
1.00 1.30 0.30 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 2,500 $ 1.1416 $ 2,854 2,853 0.4101 - 1.56
Last Trade Time Type Quantity Stock Price Currency
13:22:18 400 $ 1.15 USD

Cell Source (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.46M 29.97M 6.25M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
50.00 $ - 0.00% - -

more financials information »

Cell Source (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLCS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.191.191.141.151,375-0.04-3.36%
1 Month0.801.200.751.043,3070.3543.75%
3 Months0.751.560.751.103,6840.4053.33%
6 Months0.501.560.460.9546384,2160.65130.0%
1 Year0.781.560.41010.83874783,7850.3747.44%
3 Years0.401.560.15020.53280696,5380.75187.5%
5 Years1.401.560.15020.57860447,007-0.25-17.86%

Cell Source (QB) Description

We are currently continuing with research and development of the patented technology which we license from the laboratory to the clinic. We have recently commenced a clinical trial in the US. Our planned principal operations are the development and commercialization of new cell therapy products focused on the treatment of blood cancers and nonmalignant blood disorders as well as the facilitation of safer and more accessible organ transplantations.


Your Recent History
USOTC
CLCS
Cell Sourc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.